缩写名/全名 |
HELICOBACTER
HELICOBACTER |
||||||||||||||||||||
ISSN号 | 1083-4389 | ||||||||||||||||||||
研究方向 | 医学-微生物学 | ||||||||||||||||||||
影响因子 | 2015:3.92, 2016:3.429, 2017:4.123, 2018:3.352, 2019:4, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||
年文章数 | 84 | ||||||||||||||||||||
出版年份 | 1996 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2月 |
||||||||||||||||||||
录用比例 | 一般 | ||||||||||||||||||||
投稿链接 | |||||||||||||||||||||
投稿官网 | http://wiley.helicobacter.cn/ | ||||||||||||||||||||
h-index | 71 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1083-4389%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview. Author: Chauhan N1, Tay ACY2,3, Marshall BJ2, Jain U1. Journal: Helicobacter. 2019 Feb;24(1):e12544. doi: 10.1111/hel.12544. Epub 2018 Oct 16. PubMed DOI |
2. | Recruitment of CCR6+ Foxp3+ regulatory gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Author: Wu YY1,2,3, Hsieh CT4, Tsay GJ5,6, Kao JT6,7, Chiu YM8,9, Shieh DC8, Lee YJ10. Journal: Helicobacter. 2019 Feb;24(1):e12550. doi: 10.1111/hel.12550. Epub 2018 Nov 9. PubMed DOI |
3. | Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI. Author: Graham DY1, Lu H2,3, Dore MP4. Journal: Helicobacter. 2019 Feb;24(1):e12554. doi: 10.1111/hel.12554. Epub 2018 Nov 15. PubMed DOI |
4. | The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis. Author: Zhan Y1, Si M1, Li M1, Jiang Y1. Journal: Helicobacter. 2019 Apr;24(2):e12562. doi: 10.1111/hel.12562. Epub 2019 Jan 22. PubMed DOI |
5. | Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases. Author: Chen Q1, Liang X1, Long X1, Yu L1, Liu W1, Lu H1,2. Journal: Helicobacter. 2019 Apr;24(2):e12563. doi: 10.1111/hel.12563. Epub 2019 Jan 22. PubMed DOI |
6. | Helicobacter pylori infection alters gastric and tongue coating microbial communities. Author: Zhao Y1, Gao X2,3, Guo J1, Yu D4, Xiao Y5, Wang H1, Li Y1. Journal: Helicobacter. 2019 Apr;24(2):e12567. doi: 10.1111/hel.12567. Epub 2019 Feb 7. PubMed DOI |
7. | Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial. Author: Lu B1, Wang J2, Li J3, Liu L1, Chen Y1. Journal: Helicobacter. 2019 Apr;24(2):e12566. doi: 10.1111/hel.12566. Epub 2019 Feb 19. PubMed DOI |
8. | Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study. Author: Wang T1,2, Yang X1,2, Li Y1,2, Li L1,2, Liu J1,2, Ji C1,2, Sun Y1,2, Li Y1,2, Zuo X1,2. Journal: Helicobacter. 2019 Jun;24(3):e12569. doi: 10.1111/hel.12569. Epub 2019 Mar 8. PubMed DOI |
9. | Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies. Author: Zhou BG1, Yang HJ2, Xu W3, Wang K4, Guo P5, Ai YW1. Journal: Helicobacter. 2019 Jun;24(3):e12576. doi: 10.1111/hel.12576. Epub 2019 Mar 25. PubMed DOI |
10. | Recognition of Helicobacter pylori by protein-targeting aptamers. Author: Yan W1,2,3,4, Gu L1,2,3,4, Ren W1,4,5, Ma X1,2,3,4, Qin M1,2,3,4, Lyu M1,2,3,4, Wang S1,2,3,4. Journal: Helicobacter. 2019 Jun;24(3):e12577. doi: 10.1111/hel.12577. Epub 2019 Apr 4. PubMed DOI |
|
|